Who owns Intercept Pharmaceuticals In Note 2.000 5/1 bnd?

Top Holders and Investors of Intercept Pharmaceuticals In Note 2.000 5/1 bnd Stock

Find out what company owns Intercept Pharmaceuticals In Note 2.000 5/1 bnd, who bought Intercept Pharmaceuticals In Note 2.000 5/1 bnd this quarter, and who sold shares of Intercept Pharmaceuticals In Note 2.000 5/1 bnd stock?

Fund or Company Name Number of Shares Valued At As Of
Highbridge Capital Management 20.00M $19.80M Jun 2019
Citadel Advisors 12.50M $12.38M Jun 2019
Polar Securities 10.00M $10.00M Jun 2019
Nomura Holdings 10.00M $0 Jun 2019
Allianz Asset Management AG 8.63M $8.54M Jun 2019
Wellington Management Company 8.62M $8.54M Jun 2019
SSI Investment Management 6.15M $6.09M Jun 2019
Fmr 5.05M $5.00M Jun 2019
CNH Partners 5.00M $4.95M Jun 2019
Rima Management 5.00M $5.00M Jun 2019
Calamos Advisors 5.00M $5.00M Jun 2019
Context Capital Management 2.50M $2.48M Jun 2019
Bnp Paribas Arbitrage, Snc 1.76M $1.74M Jun 2019
Goldman Sachs 352000 $348480 Jun 2019
Gabelli Securities 300000 $300000 Jun 2019
SG Americas Securities 95000 $9.45M Jun 2019
Wells Fargo & Company 39000 $39000 Jun 2019